David Hendren is the Chief Business Officer of QURA, Inc., a Massachusetts medical technology company building an implantable sensor that streams real-time blood-pressure data to patients and physicians. A lawyer by training who has spent more than 25 years working every side of the deal table - venture capitalist, entrepreneur, CEO, board chair, advisor and counsel - he co-founded QURA in 2013 alongside its CEO. He also runs the advisory firm Augmentum Advisors, mentors startups through MassChallenge, sits on a Massachusetts Life Sciences Center review board, and advises VIC Technology Ventures, focusing his career on financing and commercializing healthcare and biomedical innovation.
William G. Hendren, MD, MBA is the co-founder and CEO of QURA, Inc., a Duxbury, Massachusetts medical technology company building the QSmart platform - an implantable biosensor roughly the size of a grain of rice that continuously measures and wirelessly transmits medical-grade blood pressure data in real time. A surgeon trained at Harvard, Mass General, Emory and the Cleveland Clinic, with an MBA and strategic healthcare consulting experience at PwC across the US, Middle East, China and the UK, Hendren is taking aim at hypertension, which he calls the single leading healthcare threat in the world.